Sinanovic E - Search Results

1

Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis.

Schnippel K, Firnhaber C, Conradie F, Ndjeka N, Sinanovic E. Schnippel K, et al. Among authors: sinanovic e. Appl Health Econ Health Policy. 2018 Feb;16(1):43-54. doi: 10.1007/s40258-017-0352-8. Appl Health Econ Health Policy. 2018. PMID: 28980217

2

Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa.

Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, Maher D. Sinanovic E, et al. Int J Tuberc Lung Dis. 2003 Sep;7(9 Suppl 1):S56-62. Int J Tuberc Lung Dis. 2003. PMID: 12971655

3

Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa.

Hausler HP, Sinanovic E, Kumaranayake L, Naidoo P, Schoeman H, Karpakis B, Godfrey-Faussett P. Hausler HP, et al. Among authors: sinanovic e. Bull World Health Organ. 2006 Jul;84(7):528-36. doi: 10.2471/blt.04.018606. Bull World Health Organ. 2006. PMID: 16878226 Free PMC article.

4

Sharing the burden of TB/HIV? Costs and financing of public-private partnerships for tuberculosis treatment in South Africa.

Sinanovic E, Kumaranayake L. Sinanovic E, et al. Trop Med Int Health. 2006 Sep;11(9):1466-74. doi: 10.1111/j.1365-3156.2006.01686.x. Trop Med Int Health. 2006. PMID: 16930269 Free article.

5

The motivations for participation in public-private partnerships for the provision of tuberculosis treatment in South Africa.

Sinanovic E, Kumaranayake L. Sinanovic E, et al. Glob Public Health. 2010;5(5):479-92. doi: 10.1080/17441690902942498. Glob Public Health. 2010. PMID: 19479590 Free article.

6

The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa.

Sinanovic E, Moodley J, Barone MA, Mall S, Cleary S, Harries J. Sinanovic E, et al. Vaccine. 2009 Oct 19;27(44):6196-202. doi: 10.1016/j.vaccine.2009.08.004. Epub 2009 Aug 19. Vaccine. 2009. PMID: 19698807

7

Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa.

Channing L, Sinanovic E. Channing L, et al. Among authors: sinanovic e. Cost Eff Resour Alloc. 2014 Sep 16;12:20. doi: 10.1186/1478-7547-12-20. eCollection 2014. Cost Eff Resour Alloc. 2014. PMID: 25242892 Free PMC article.

8

Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa.

Sinanovic E, Ramma L, Vassall A, Azevedo V, Wilkinson L, Ndjeka N, McCarthy K, Churchyard G, Cox H. Sinanovic E, et al. Int J Tuberc Lung Dis. 2015 Feb;19(2):172-8. doi: 10.5588/ijtld.14.0421. Int J Tuberc Lung Dis. 2015. PMID: 25574915 Free PMC article.

9

The economic burden of TB diagnosis and treatment in South Africa.

Foster N, Vassall A, Cleary S, Cunnama L, Churchyard G, Sinanovic E. Foster N, et al. Among authors: sinanovic e. Soc Sci Med. 2015 Apr;130:42-50. doi: 10.1016/j.socscimed.2015.01.046. Epub 2015 Jan 27. Soc Sci Med. 2015. PMID: 25681713 Free article.

10

Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa.

Cox H, Ramma L, Wilkinson L, Azevedo V, Sinanovic E. Cox H, et al. Among authors: sinanovic e. Trop Med Int Health. 2015 Oct;20(10):1337-45. doi: 10.1111/tmi.12544. Epub 2015 Jun 1. Trop Med Int Health. 2015. PMID: 25975868 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters